Drug intelligence / Profile preview

AdiaVita

Development stage
Phase 2
Lead developer
ADIA Nutrition
Modality
Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

AdiaVita is an investigational regenerative biologic product developed by Adia Med. It is described in registered clinical studies as a preparation of umbilical cord blood-derived stem cells and exosomes, administered intravenously. The product is being evaluated alone or alongside glutathione in early-stage studies for autism spectrum disorder, chronic kidney disease, and chronic mechanical lower back pain. Its precise cellular composition, exosome characterization, potency assay, and target-specific mechanism of action have not been publicly established. AdiaVita is not an approved therapy.

Brand names
AdiaVitaAdia Vita
Other names
umbilical cord blood-derived stem cells and exosomesumbilical cord blood plasma combined with mononuclear cellsUCB-PM

Beyond the preview

Go deeper on AdiaVita.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AdiaVita.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call